Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Intelligent Bio Solutions (INBS) Total Non-Current Liabilities (2023)

Intelligent Bio Solutions has reported Total Non-Current Liabilities over the past 1 years, most recently at $5.7 million for Q4 2023.

For Q4 2023, Total Non-Current Liabilities changed N/A year-over-year to $5.7 million; the TTM value through Dec 2023 reached $5.7 million, changed N/A, while the annual FY2023 figure was $6.7 million, N/A changed from the prior year.
Total Non-Current Liabilities for Q4 2023 was $5.7 million at Intelligent Bio Solutions, down from $6.7 million in the prior quarter.
Over five years, Total Non-Current Liabilities peaked at $6.7 million in Q2 2023 and troughed at $5.7 million in Q4 2023.